The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kbc Groep NV
OTC:KBCSF
|
BE |
|
Merdeka Copper Gold Tbk PT
F:B0C
|
ID |
|
N
|
Nifco Inc
OTC:NIFCY
|
JP |
|
Cinda International Holdings Ltd
F:HNT
|
HK |
|
Banca Mediolanum SpA
MIL:BMED
|
IT |
|
CPI Card Group Inc
NASDAQ:PMTS
|
US |
|
C
|
CMOC Group Ltd
OTC:CMCLF
|
CN |
|
Fresenius Medical Care AG & Co KGaA
NYSE:FMS
|
DE |
|
C
|
Charles Schwab Corp
DUS:SWG
|
US |
|
Cimpress PLC
NASDAQ:CMPR
|
IE |
|
Orora Ltd
ASX:ORA
|
AU |
|
P
|
Palfinger AG
XMUN:PFI
|
AT |
|
Frontier Group Holdings Inc
NASDAQ:ULCC
|
US |
|
Commercial Syn Bags Ltd
NSE:COMSYN
|
IN |
|
Sinclairs Hotels Ltd
NSE:SINCLAIR
|
IN |
|
Marathon Petroleum Corp
NYSE:MPC
|
US |
|
P
|
Pax Global Technology Ltd
OTC:PXGYF
|
HK |
|
P
|
Pentair PLC
SWB:PNT
|
UK |
|
Amplitude Inc
NASDAQ:AMPL
|
US |
|
NBI Bearings Europe SA
MAD:NBI
|
ES |
|
C
|
Cardinal Health Inc
LSE:0HTG
|
US |
|
C
|
China Longyuan Power Group Corp Ltd
OTC:CLPXF
|
CN |
|
E
|
Ecolab Inc
XMUN:ECJ
|
US |
|
E
|
Entergy Corp
SWB:ETY
|
US |
Kbc Groep NV (KBCSF)’s 12-month stock price forecast through October 2027 has a consensus target of $162.73, implying 26% upside. The forecast is based on price targets from 25 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
KBCSF is 162.73 USD with a low forecast of 103.5 USD and a high forecast of 193.19 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 4 years is 2%.
The compound annual growth rate for Net Income over the next 4 years is 10%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more